257 related articles for article (PubMed ID: 21523891)
21. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
Džavík V; Colombo A
JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424
[TBL] [Abstract][Full Text] [Related]
22. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C
Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
Brugaletta S; Garcia-Garcia HM; Diletti R; Gomez-Lara J; Garg S; Onuma Y; Shin ES; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Chevalier B; McClean D; Windecker S; Whitbourn R; Dorange C; Veldhof S; Rapoza R; Sudhir K; Bruining N; Ormiston JA; Serruys PW
EuroIntervention; 2011 Apr; 6(9):1110-6. PubMed ID: 21518685
[TBL] [Abstract][Full Text] [Related]
24. Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies.
Gogas BD; Radu M; Onuma Y; Perkins L; Powers JC; Gomez-Lara J; Farooq V; Garcia-Garcia HM; Diletti R; Rapoza R; Virmani R; Serruys PW
Int J Cardiovasc Imaging; 2012 Mar; 28(3):499-511. PubMed ID: 21503708
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
Serruys PW; Onuma Y; Garcia-Garcia HM; Muramatsu T; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Ormiston JA
EuroIntervention; 2014 Mar; 9(11):1271-84. PubMed ID: 24291783
[TBL] [Abstract][Full Text] [Related]
26. Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
Brugaletta S; Gomez-Lara J; Bruining N; Radu MD; van Geuns RJ; Thuesen L; McClean D; Koolen J; Windecker S; Whitbourn R; Oberhauser J; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
EuroIntervention; 2012 Jul; 8(3):352-8. PubMed ID: 22130182
[TBL] [Abstract][Full Text] [Related]
27. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
28. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
[TBL] [Abstract][Full Text] [Related]
29. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH).
Simsek C; Magro M; Onuma Y; Boersma E; Smits P; Dorange C; Veldhof S; Regar E; Serruys PW; van Geuns RJ
EuroIntervention; 2014 Jun; 10(2):236-40. PubMed ID: 23999210
[TBL] [Abstract][Full Text] [Related]
30. Assessment of bioresorbable scaffold with a novel high-definition 60 MHz IVUS imaging system: Comparison with 40-MHz IVUS referenced to optical coherence tomography.
Okada K; Kitahara H; Mitsutake Y; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Ikeno F; Honda Y
Catheter Cardiovasc Interv; 2018 Apr; 91(5):874-883. PubMed ID: 28707349
[TBL] [Abstract][Full Text] [Related]
31. Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.
Zeng Y; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Abdelghani M; Jonker H; Digne F; Horstkotte D; Zehender M; Indolfi C; Saia F; Fiorilli R; Chevalier B; Bolognese L; Goicolea J; Nie S; Onuma Y; Serruys PW;
Int J Cardiovasc Imaging; 2017 Apr; 33(4):441-449. PubMed ID: 28012050
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study.
Shin ES; Garcia-Garcia HM; Garg S; Ligthart J; Thuesen L; Dudek D; Ormiston JA; Serruys PW
Int J Cardiovasc Imaging; 2011 Oct; 27(7):931-7. PubMed ID: 21080074
[TBL] [Abstract][Full Text] [Related]
33. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.
Serruys PW; Onuma Y; Dudek D; Smits PC; Koolen J; Chevalier B; de Bruyne B; Thuesen L; McClean D; van Geuns RJ; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Sudhir K; Garcia-Garcia HM; Ormiston JA
J Am Coll Cardiol; 2011 Oct; 58(15):1578-88. PubMed ID: 21958884
[TBL] [Abstract][Full Text] [Related]
35. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
[TBL] [Abstract][Full Text] [Related]
36. Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial.
Sotomi Y; Ishibashi Y; Suwannasom P; Nakatani S; Cho YK; Grundeken MJ; Zeng Y; Tateishi H; Smits PC; Barragan P; Kornowski R; Gershlick AH; Windecker S; van Geuns RJ; Bartorelli AL; de Winter RJ; Tijssen J; Serruys PW; Onuma Y
JACC Cardiovasc Interv; 2016 Jun; 9(12):1216-1227. PubMed ID: 27339838
[TBL] [Abstract][Full Text] [Related]
37. Reproducibility of quantitative optical coherence tomography for stent analysis.
Gonzalo N; Garcia-Garcia HM; Serruys PW; Commissaris KH; Bezerra H; Gobbens P; Costa M; Regar E
EuroIntervention; 2009 Jun; 5(2):224-32. PubMed ID: 19527980
[TBL] [Abstract][Full Text] [Related]
38. Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
Brugaletta S; Gomez-Lara J; Garcia-Garcia HM; Heo JH; Farooq V; van Geuns RJ; Chevalier B; Windecker S; McClean D; Thuesen L; Whitbourn R; Meredith I; Dorange C; Veldhof S; Rapoza R; Ormiston JA; Serruys PW
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1307-14. PubMed ID: 22108907
[TBL] [Abstract][Full Text] [Related]
39. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.
Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ
EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042
[TBL] [Abstract][Full Text] [Related]
40. First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study.
Hideo-Kajita A; Garcia-Garcia HM; Haude M; Joner M; Koolen J; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Teik LS; Escaned J; Azizi V; Kuku KO; Ozaki Y; Dan K; Waksman R
Cardiovasc Revasc Med; 2019 May; 20(5):392-398. PubMed ID: 31079817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
